SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
RNAi
An SI Board Since May 2003
Posts SubjectMarks Bans
671 52 0
Emcee:  tuck Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
146>>PNAS | January 13, 2004 | vol. 101 | no. 2 | 488-493 Analysis of C5a-metuck-1/13/2004
145>>LOS ANGELES, Jan. 13 /PRNewswire-FirstCall/ -- Further expanding its coltuck-1/13/2004
144Alnylam Licenses Fundamental Patent in RNA Interference to Invitrogen Tuesday Janigel bates-1/13/2004
143Alnylam Licenses Fundamental Patent in RNA Interference to Cell Signaling Technonigel bates-1/13/2004
142Alnylam And Cenix Bioscience Enter Into Research Alliance and Licensing Agreemennigel bates-1/13/2004
141Sirna Therapeutics to Present at the JP Morgan Healthcare Conference Monday JanSemiBull-1/12/2004
140Did anyone post the link for the Nature Reviews focus on RNAi ? If not , it'nigel bates-1/7/2004
139Sirna Therapeutics Announces Management Changes, Promotions Tuesday December 23SemiBull-1/4/2004
138Thanks a lot, Tuck. Appreciate the english translation! Happy Holidays to all.Thomas-12/22/2003
137These folks have developed a system that can help elucidate critical pathways intuck-12/20/2003
136Hi Tuck, Thanks for the abstract. What does it mean? TIA. Cheers, ThomasThomas-12/20/2003
135>>Published online before print December 19, 2003 Proc. Natl. Acad. Sci. Utuck-12/19/2003
134QIAGEN has Licensed a Novel Algorithm Developed by Novartis Pharma AG for the Senigel bates-12/15/2003
133Dharmacon Launches siSTABLE(TM) siRNA With Greatly Increased Stability and Extennigel bates-12/15/2003
132Tuck, Don't know if you noticed, but the December Nat. Biotech. has a Featukeokalani'nui-12/10/2003
131Milestone Strategic Agreement to Commercialise Australian Biotech Innovation Monnigel bates-12/8/2003
130From my Google alerts: Invitrogen boosts RNAi tech with Sequitur deal By Nancy Thomas-12/3/2003
129Thanks, and please keep posting. Meanwhile here's a free full text article:tuck-12/1/2003
128I recently attended a seminar by Dr David Morrisey from Sirna Therapeutics (RNAIAuBug-11/25/2003
127Hi SemiBull, This is interesting as it is one of the key targets that Sirna is aThomas-11/25/2003
126The Journal of Biology has a number of free articles on RNAi: jbiol.com I thintuck-11/21/2003
125Acuity Pharmaceuticals to Present First Demonstration of siRNA Therapeutic EfficSemiBull-11/10/2003
124Sirna Therapeutics Reports Third Quarter Financial Results Tuesday November 4, 8SemiBull-11/5/2003
123Sirna Therapeutics Appoints Ivan Richards, Ph.D. to Lead Its Pharmacology Group SemiBull-11/5/2003
122link for q report biz.yahoo.com i'm interested in comments on the balance sbob zagorin-11/4/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News